Find clinical trials for Pancreatic Cancer in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Barcelona, CT, ESP:
Patients with metastatic pancreatic cancer and germline mutation in BRCA have benefit of therapy with PARP inhibitors. In addition,...
Phase 2
Barcelona, Spain and 2 other locations
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Barcelona, Spain and 89 other locations
Randomized, Open-Label Clinical Study of GB201 in Combination with Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Metastatic Pancreatic...
Phase 2, Phase 3
Barcelona, Spain and 37 other locations
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...
Phase 2
Barcelona, Spain and 16 other locations
In order to improve the survival rates and decrease progression of pancreatic advanced cancer, this study aims to evaluate the firs...
Phase 1, Phase 2
Barcelona, Cataluña, Spain and 5 other locations
regimen gemcitabine/nab-paclitaxel in patients with metastatic pancreatic cancer who are treatment-naïve in the advanced disease se...
Phase 1
Barcelona, Spain and 3 other locations
treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in t...
Phase 1, Phase 2
Barcelona, Spain and 26 other locations
Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic du...
Phase 1, Phase 2
Barcelona, Spain and 15 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Barcelona, Spain and 91 other locations
This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in com...
Phase 2
Barcelona, Spain and 21 other locations
Clinical trials
Research sites
Resources
Legal